Embedded Files
Wikipedia 🌐 NONE
Wikipedia 🌐 NONE
https://www.upstate.edu/news/articles/2022/2022-11-18-chair.php
2022-11-18-update-edu-news-chair.pdf
2022-11-18-update-edu-news-chair-img-1.jpg
2022-11-18-chair.jpg (portrait)
Stephen J. Thomas, MD, named the Frank E. Young, MD ’56 and Leanne Young Endowed Chair of Microbiology
Stephen J. Thomas, MD, named the Frank E. Young, MD ’56 and Leanne Young Endowed Chair of Microbiology
Stephen J. Thomas, MD, has been named the Frank E. Young, MD ’56 and Leanne Young Endowed Chair of Microbiology. The appointment, effective immediately, was announced by Norton College of Medicine Dean Lawrence Chin, MD.
Thomas, who joined Upstate in 2016, became one the nation’s leading and most authoritative voices regarding the COVID-19 pandemic, offering his perspective of the pandemic in both local and national media, updating the public on vaccines, masking, treatments and clinical trials since the pandemic was declared a global outbreak in March 2020.
“There is no individual more worthy than Dr Thomas to serve as our new endowed chair of Microbiology,” Chin said. “Dr Thomas has distinguished himself at every turn, whether through his service in the Armed Forces, as a principal investigator for the Pfizer/BioNTech Covid vaccine efficacy trial, as director of Upstate’s Institute for Global Health and Translational Science, or division chief of Infectious Disease. He has made significant contributions to our university that has benefited all of us.
“To be serving as an endowed chair named for Upstate alumnus Dr. Frank E. Young, a former commissioner of the Food and Drug Administration, makes this appointment even more appropriate,” Chin added.
At Upstate, Thomas has held several positions: chief of the Infectious Diseases Division (2016 to 2021) directed of the Institute for Global Health and Translational Science (since 2018), and interim chair of Department of Microbiology and Immunology.
Prior to joining Upstate, Thomas spent 20 years in the U.S. Army serving at the Walter Reed Army Institute of Research and completing his career as the institute’s Deputy Commander for Operations (Chief Operating Office). He also served as the infectious diseases consultant to the U.S. Army Surgeon General and U.S. Central Command’s regional infectious diseases expert during a deployment in the Middle East.
In November 2020, Thomas was tapped as lead principal investigator for the world-wide Pfizer/BioNTech vaccine trial. Thanks to Thomas and Upstate’s Global Health team, Central New Yorkers had an opportunity to participate in making history as the area became one of the study’s global phase 3 vaccine trial locations. Thomas also led the team coordinating the university’s initial response to the pandemic in March 2020.
The endowed chair post that Thomas will fill is named for former FDA commissioner Frank E. Young, MD, PhD, (1984 to 1989) and his wife, Leanne. Young, who received his medical degree from Upstate in 1956, provided over several key FDA events, including approval of the first drug to combat AIDS. His federal service also included a term as director of the office of Emergency Preparedness.
“I am very happy I chose to follow my mentor and former Walter Reed colleagues to Upstate. It has been a great place to work and for me and my family to make a home,” Thomas said. “And to share in the legacy of Dr. Young makes this appointment even more special.”
https://www.forbes.com/sites/stephenthomas/
https://www.forbes.com/sites/stephenthomas/
Stephen J. Thomas, M.D.
Stephen J. Thomas, M.D.
Follow
Contributor|HEALTHCARE
I’m the Director of the Global Health Institute and Frank E. Young, MD ’56 and Leanne Young Endowed Chair of Microbiology & Immunology at SUNY Upstate Medical University (Syracuse, New York). I lead a cross-functional team developing medical countermeasures to combat public health problems and a department of basic science virologists, immunologists, and vector biologists. I’m originally from Albany, New York, and attended Brown University and Albany Medical College. I joined the U.S. Army and completed my internal medicine and infectious diseases training at the Walter Reed Army Medical Center. I spent 20 years in the Army biomedical research and development enterprise and lived and worked in Thailand and Southeast Asia for six of those years. I am also a co-founder and/or board member of start-ups in the biotech, SaaS, and life science consulting spaces. My wife, two children, and I live a 'lake life' in the New York State Finger Lakes region.
Comment
N Engl J Med
. 2017 May 11;376(19):1883-1886.doi: 10.1056/NEJMcibr1701402.
Zika Virus Vaccines - A Full Field and Looking for the Closers
Zika Virus Vaccines - A Full Field and Looking for the Closers
Affiliations expand
PMID: 28490001
Free article
No abstract available
Global Health Institute
Home»thomas stephen
Stephen Thomas
Stephen Thomas
Director, Upstate Global Health Institute
Director, Upstate Global Health Institute
thomstep@upstate.edu
315-464-7692
Dr. Stephen Thomasis an Infectious Diseases physician-scientist from SUNY Upstate Medical University in Syracuse, NY, USA. He is a Professor of Medicine and Professor of Microbiology & Immunology. Dr. Thomas currently directs the Upstate Global Health Institute and is the Frank E. Young, MD '56 and Leanne Young Endowed Chair of Microbiology & Immunology. Dr. Thomas earned his Bachelor of Arts with Honors in Biomedical Ethics from Brown University, his Medical Degree from Albany Medical College, and completed his Internal Medicine residency and Infectious Diseases fellowship at the Walter Reed Army Medical Center and the National Capital Consortium. Prior to joining Upstate, Dr. Thomas served in the U.S. Army at the Walter Reed Army Institute of Research and completed his career as the institute's Deputy Commander for Operations. He also served as the Infectious Diseases Consultant to the U.S. Army Surgeon General. Dr. Thomas specializes in the study of infectious diseases with a focus on diseases caused by viruses. He spent more than five years of his early military career living and working in Thailand and Southeast Asia. Dr. Thomas played key leadership roles in the U.S. government response to the West Africa Ebola outbreak (2014-2016) and advised senior government leaders during the planning and execution of the Obama Administration's Operation United Assistance. He represented the Department of Defense in the U.S. government response to the MERS-CoV and Zika epidemics. Dr. Thomas served as the global coordinating principal investigator for the Pfizer / BioNTech COVID vaccine efficacy trial. Dr. Thomas serves on numerous advisory boards for the US government, non-governmental organizations such as the WHO and CEPI, and industry. He is a contributor to Forbes magazine and entrepreneur, co-founding start-ups in life sciences consulting, biotech, and digital marketplaces.
https://www.upstate.edu/search/?tab=people&ID=thomstep&q=stephen%20thomas
https://pubmed.ncbi.nlm.nih.gov/?term=Thomas+SJ&cauthor_id=33301246
N Engl J Med
. 2016 Sep 29;375(13):1212-6. doi: 10.1056/NEJMp1609300.
Fast-Track Zika Vaccine Development - Is It Possible?
Fast-Track Zika Vaccine Development - Is It Possible?
Stephen J Thomas 1, Maïna L'Azou 1, Alan D T Barrett 1, Nicholas A C Jackson 1
Affiliations expand
PMID: 27682032
DOI: 10.1056/NEJMp1609300
Free article
No abstract available
·
We are proud to have Dr. Stephen J. Thomas, MD as a board member and current co-vice chair of our CNY Lyme and Tick-Borne Disease Alliance board. In addition to his impressive resume and selfless support of the Alliance, he’s working tirelessly to help CNY battle the current COVID-19 crisis that’s ravaging our country. Read on and get to know a little bit more about Dr. Thomas…
STEPHEN J. THOMAS, MD
Board Vice Chair, CNY Lyme and Tick-Borne Disease Alliance
Chief, Division of Infectious Diseases, SUNY Upstate Medical University
Professor of Medicine
Professor of Microbiology and Immunology
Co-Founder and Chief Executive Officer, Cormac Life Sciences, LLC
Stephen J. Thomas, MD, senior physician, scientist, organizational leader and entrepreneur, has biomedical research and development (R&D) expertise with a proven 16-year track record demonstrating highly effective, innovative and strategic leadership of projects, programs and institutions. His focus is on infectious disease medical countermeasure development, bio-preparedness and global health security.
What paid or volunteer position(s) have you held that pertain to your board membership?
• Member. Board of Managers, YMCA, Skaneateles, NY
• Co-founder. Director of Strategy. GreenMark Partners
• Co-founder. CEO. Cormac Life Sciences, LLC
• Member. Scientific Advisory Board, Moderna, Cambridge, Massachusetts
• Member. Takeda Dengue Vaccine Advisory Board, Boston, MA
• Member. Merck Dengue Vaccine Advisory Board, West Point, PA
• Member. Scientific Advisory Board, PrimeVax Immunology-Oncology, Orange, California
• Member. Scientific Advisory Board, Themisbio, Vienna, Austria
• Member. Sanofi Pasteur, Vaccine Research Advisory Board
• Member. Dengue Vaccine Expert Advisory Board, Sanofi Pasteur, Lyon, France
• Chair. Dengue Illness Adjudication Committee, Takeda Pharmaceuticals, Zurich, Switzerland
• Treasurer. Medical Executive Committee, SUNY Upstate Medical University, Syracuse, NY
• Member. Medical Executive Committee, SUNY Upstate Medical University
What are you doing now?
GREENMARK PARTNERS
Co-Founder and Director of Strategy (August 2019 – present)
Skaneateles, NY
• Co-founder and Strategy Director for a company providing personalized and specialty-specific physician compensation and productivity information and analytics.
• Advise the GreenMark leadership team on industry and market trends, competitive threats, and business opportunities. Provide guidance on new market opportunities and the development and launch of new products or the dissolving of existing products.
• Work closely with the Director, Sales and Marketing to transition strategy into new client engagement, acquisition, and management.
STATE UNIVERSITY OF NEW YORK (SUNY) UPSTATE MEDICAL UNIVERSITY
Director, Institute for Global Health and Translational Sciences (March 2018 – present)
Syracuse, NY, USA
• Provide strategic leadership and technical expertise to a University level institute supporting global health and translational science initiatives across the University’s four colleges (Medicine, Nursing, Graduate Studies, Health Professions).
• Identify, engage, and lead the execution of educational, research, and clinical service learning opportunities across the Institute’s numerous Centers to include International Research, Clinical Research, Education and Training, Biomanufacturing, and Environmental Health and Medicine).
• Lead the development of a strategic plan detailing the Institute’s 2-5-year growth and sustainment trajectory supporting the University wide strategic plan.
• Lead the development of a business plan detailing the Institute’s planned utilization of 2 years of capital University investment and the Institute’s strategy for ensuring operational and financial efficiencies and maximizing potential financial returns on investment with a goal of financial self-sustainment by year 4.
STATE UNIVERSITY OF NEW YORK (SUNY) UPSTATE MEDICAL UNIVERSITY
Chief, Division of Infectious Diseases (November 2016 – present)
Professor of Medicine
Professor of Microbiology and Immunology
Syracuse, NY, USA
• Direct report to the Chair, Department of Medicine and senior report to the Dean, College of Medicine, Upstate Medical University. Support the SUNY Upstate mission to improve community health by leading medical education initiatives, executing innovative biomedical research and translational science, and providing high quality sub-specialty health care.
• Lead the Division’s strategic planning process and implementation of identified initiatives across the pillars of health care delivery, medical education, and research.
• Lead a staff of Infectious Diseases physicians, mid-level providers, and support staff ensuring professional, academic, and institutional goals and objectives are established and achieved.
• Lead the identification, analysis, and pursuit of business development initiatives ensuring financial profitability and promoting growth.
• Coordinate and partner with Upstate Departments, Centers, and Divisions on the identification, planning, and execution of basic, translational, and clinical research.
• Work with the ID Fellowship Director and faculty colleagues to build a high quality and sought-after fellowship program training the next generation of Infectious Diseases specialist.
• Identify and engage regional, national, and global partners to facilitate meeting institutional strategic objectives.
Cormac Life Sciences, LLC.
Co-Founder and Chief Executive Officer (March 2016 – present)
Skaneateles, NY, USA
• Co-founder and CEO of a Service-Disabled Veteran-Owned Small Business (SDVOSB) registered in New York State. Verified by the Veterans Administration and certified by New York State as a SDVOSB. Our mission is to support life science basic, translational, and clinical research initiatives with a focus on biopreparedness and medical countermeasure development.
• Past performance proving expert consultation and counsel for biotech, big pharma, government entities, academia, and non-governmental organizations.
What is your educational/professional background?
• BA, Biomedical Ethics, Brown University
• MD, Albany Medical College
• Resident, Internal Medicine, Walter Reed Army Medical Center
• Fellow, infectious diseases, National Capital Consortium
• Certificate in Tropical Medicine and Traveler’s Health, American Society of Tropical Medicine and Hygiene
• Association of Military Surgeons of the United States
• Infectious Diseases Society of America (IDSA);
• America Society of Tropical Medicine and Hygiene (ASTMH)
• Virology Association of Thailand
• Armed Forces Infectious Diseases Society (AFIDS)
• American College of Physicians (ACP)
Is there a project you are most proud to have been a part of? Why and what was your role?
My last job in the Army was as the Deputy Commander, Walter Reed Army Institute of Research (WRAIR). The Deputy Commander position is a Chief Operating Officer position and my responsibilities included 2100 staff, $300M per year, with laboratory assets on four continents. During my two-year tenure I used my leadership position to build partnerships and secure funding to advance three epidemic vaccine candidates to human testing – Ebola, Zika, and MERS-CoV. The Ebola vaccine was recently licensed in Europe and the US and is being used to stop the current outbreak in the DRCongo.
What are you most excited about in the work of the Alliance?
Being able to leverage my clinical and research expertise to address a significant health problem in my community.
Who is the person who influenced you most in the path you’ve taken in life?
Dr. Tim Endy. Tim was an infectious diseases physician in the US Army and motivated me to become an infectious diseases physician and pursue a career in research. He mentored me throughout my Army career and when he moved to Upstate, I followed 10 years later. Tim has been a consistent source of friendship, counsel and expertise for 21 years.
What’s a great book, musician, movie, exhibit, play or experience you’ve read/seen/had recently you would recommend?
Platform Scale by Sangeet Paul Choudary
What would you like to share about your family?
I have been married to Erica for 21 years and we have 2 children; Charlie 12 and Laney 4.See less
https://www.biospace.com/stephen-j-thomas-m-d-joins-rheonix-board-and-executive-team
2022-07-21-biospace-com-stephen-j-thomas-rheonix.pdf
2022-07-21-biospace-com-stephen-j-thomas-rheonix-img-1.jpg
Stephen J. Thomas, M.D., Joins Rheonix Board and Executive Team
Stephen J. Thomas, M.D., Joins Rheonix Board and Executive Team
July 21, 2022 | 2 min read
Rheonix Inc., an innovative leader in highly multiplexed pathogen detection, announced the appointment of Stephen J. Thomas, M.D., as Chief Medical Officer and member of the Rheonix Board of Directors.
Rheonix Inc., an innovative leader in highly multiplexed pathogen detection, announced the appointment of Stephen J. Thomas, M.D., as Chief Medical Officer and member of the Rheonix Board of Directors.
New addition to Rheonix leadership adds expertise in infectious diseases and global epidemic response
ITHACA, N.Y.--(BUSINESS WIRE)-- Rheonix Inc., an innovative leader in highly multiplexed pathogen detection, announced the appointment of Stephen J. Thomas, M.D., as Chief Medical Officer and member of the Rheonix Board of Directors.
“I am delighted to welcome Dr. Thomas to the Rheonix Board and as our Chief Medical Officer,” said Greg Galvin, President, CEO and Chairman of the Board of Directors of Rheonix. “His extensive experience leading U.S. government responses to emerging and epidemic infectious diseases will be invaluable to Rheonix as we continue to build our clinical diagnostic portfolio.”
Dr. Thomas is a Professor of Medicine and Microbiology & Immunology at SUNY Upstate Medical University. He directs the Institute for Global Health and Translational Science and is the interim Chair of the Department of Microbiology & Immunology. Dr. Thomas also cares for patients as part of the Upstate Department of Medicine. Prior to joining Upstate, Dr. Thomas spent 20 years in the U.S. Army serving at the Walter Reed Army Institute of Research and completed his military career as the institute’s Deputy Commander for Operations. Dr. Thomas specializes in the study of viruses and vaccine development and spent more than five years of his early career living and working in Thailand. Between 2014 and 2016, he played key leadership roles in the U.S. government response to the West Africa Ebola outbreak and MERS-CoV and Zika epidemics and was instrumental in the development and advancement of vaccines for each. Currently, he is the global coordinating principal investigator for Pfizer’s phase 1/2/3 COVID vaccine trial. Dr. Thomas earned his Bachelor of Arts with Honors in Biomedical Ethics from Brown University and his medical degree from Albany Medical College, and completed his Internal Medicine residency and Infectious Diseases fellowship at Walter Reed Army Medical Center.
“I am very excited for the opportunity to work with Rheonix and support the development of their infectious diseases testing platform,” said Dr. Thomas. “COVID has reinforced how important high-quality and accessible testing is to pandemic preparedness and response.”
About Rheonix:
The Rheonix Encompass workstations enable highly multiplexed sample-to-answer molecular testing for use in clinical, research and applied testing laboratories. Rheonix’s clinical assays include the Rheonix COVID-19™ MDx Assay for use under FDA emergency use authorization and the STI TriPlex™ Assay for the detection of sexually transmitted infections in male urine. Applied testing solutions include the Beer SpoilerAlert™ Assay, the most comprehensive beer spoilage panel available and the Listeria PatternAlert™ Assay, a rapid method for Listeria strain typing. For more information, visit www.rheonix.com.
https://www.auburnhospital.org/doctor/stephen-thomas/
Specialty:Infectious Disease
Primary
Location:Upstate University Hospital
Education:Albany Medical College, Albany, NY
Fellowship:Internal Medicine / Infectious Disease, Walter Reed Army Medical Center, Bethesda, MD
Residency:Internal Medicine, Walter Reed Army Medical Center, Bethesada, MD
LOCATION
LOCATION
Address:Upstate University Hospital
Infectious Disease Associates
725 Irving Avenue
Syracuse, NY 13210
Phone:315-464-5815
BIOGRAPHY
BIOGRAPHY
Dr. Stephen J Thomas is an Infectious Disease Specialist in Syracuse, New York. He graduated with honors from Albany Medical College Of Union University in 1996.
2024-11-04-ancestry-com-stephen-j-thomas-record-62209-151246090.pdf
Stephen J Thomas
Stephen J Thomas
Add or update information
Detail Source
Name
Stephen J Thomas
Birth Date
Jun 1970
Residence Date
2000-2013
Address
25 Alfred Dr
Residence
Albany, New York, USA
Postal Code
12205
Second Residence Date
2013
Second Address
11403 Rolling House Rd
Second Residence
Rockville, Maryland, USA
Second Postal Code
20852
Third Residence Date
2004
Third Address
9512 Beck CT
Third Residence
Bethesda, Maryland, USA
Third Postal Code
20817
https://www.ancestry.com/search/collections/62209/records/98096050?tid=&pid=&queryid=e6b72b69-a7ff-4587-815c-4ef22444612f&_phsrc=kyz1711&_phstart=successSource
Stephen James Thomas
Stephen James Thomas
Add or update information
Detail Source
Name
Stephen James Thomas
[Steven J Thomas]
[Thomas Stephen James]
Birth Date
Jun 1970
Residence Date
2016-2020
Address
725 Irving Ave Ste 311
Residence
Syracuse, New York, USA
Postal Code
13210
Second Residence Date
2018
Second Address
251 Salina Meadows Pkwy Ste 100
Second Residence
Syracuse, New York, USA
Second Postal Code
13212
Third Residence Date
2014-2016
Third Address
503 Robert Grant Ave
Third Residence
Silver Spring, Maryland, USA
Third Postal Code
20910
Fourth Residence Date
2010-2016
Fourth Address
8901 Wisconsin Ave Bldg 17
Fourth Residence
Bethesda, Maryland, USA
Fourth Postal Code
20889
Stephen J Thomas
Stephen J Thomas
Add or update information
Detail Source
Name
Stephen J Thomas
Birth Date
22 Jun 1970
Address
250 Alfred Dr
Residence Place
Albany, New York, USA
Zip Code
12205
https://www.youtube.com/watch?v=fnfZHYIWju0
Professor Stephen Thomas discusses the challenges and opportunities with dengue research
Island Pharmaceuticals
17 subscribers
102 views Oct 2, 2024
In this interview, Professor Stephen Thomas MD from Upstate Global Health Institute, discusses the complexities of dengue fever, limitations with existing therapies and the potential opportunities for Island Pharmaceuticals with its Phase 2 clinical trial in dengue. With a background in the U.S. Army and extensive experience in mosquito-borne viruses, Prof. Thomas explains the challenges of developing effective dengue vaccines and treatments, and the benefits of Island's approach with a human challenge study.
https://www.youtube.com/watch?v=5UWQY2SkV-8
Wikipedia • A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019.
For information purposes only. Consult your local medical authority for advice. Learn more
Doctor talks about working with Pfizer on COVID-19 vaccine trial
KXAN
185K subscribers
Subscribe
2
Share
Save
134 views Nov 10, 2020
Dr. Stephen Thomas, the chief of the infectious disease division at Upstate University Hospital in New York, talked about working with Pfizer on the development of its COVID-19 vaccine trial.
Transcript
https://pubmed.ncbi.nlm.nih.gov/27135717/
Review
Ann Intern Med
. 2016 Aug 2;165(3):175-83. doi: 10.7326/M16-0617.Epub 2016 May 3.
The Emergence of Zika Virus: A Narrative Review
The Emergence of Zika Virus: A Narrative Review
Kathryn B Anderson, Stephen J Thomas, Timothy P Endy
PMID: 27135717
DOI: 10.7326/M16-0617
Abstract
Abstract
Zika virus (ZIKV) is yet another arbovirus that is rapidly emerging on a global scale, on the heels of a chikungunya epidemic in the Americas that began in 2013. A ZIKV epidemic that began in Brazil in 2015 has now spread rapidly to more than 30 countries in the Americas and the Caribbean, infecting more than 2 million inhabitants. This epidemic currently continues unabated. The explosive nature of recent outbreaks and concerning links to Guillain-Barré syndrome and microcephaly are incompletely understood. Also unknown is the relative importance of sexual transmission of ZIKV and asymptomatic ZIKV infections to the overall burden of transmission. The limited understanding of ZIKV presents an enormous challenge for responses to this rapidly emerging threat to human health. This article reviews the existing literature on ZIKV and proposes critical questions for vaccine development and other areas of needed research.
Full PDF :
https://sci-hub.se/10.7326/M16-0617
anderson2016.pdf
2011
Vaccines for the prevention of dengue
Development update
Stephen J. Thomas* and Timothy P.
e
ndy
Department of
v
irology; US Army Medical Component-Armed Forces
r
esearch
i
nstitute of Medical Sciences; Bangkok, Thailand;
i
nfectious Disease Division;
Department of Medicine; State University of New York; Upstate Medical University; Syracuse, NY USA
Key words:
dengue, vaccine, development, pre-clinical, clinical
Abbreviations:
DENV, dengue virus; DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome; DF, dengue fever;
LAV, live attenuated virus; PDK, primary dog kidney; WRAIR, walter reed army institute of research;
GSK, glaxosmithkline biologicals; NHP, non-human primate; EDIII, dengue virus E protein domain III;
VEE, venezuelan equine encephalitis; VRP, virus replicon particle; prM, pre-membrane; E, envelope;
NIH, national institutes of health; MVA, modified vaccinia ankara; PIV, purified inactivated virus;
PAHO, pan american health organization; WHO, world health organization; CDC, center for disease control and prevention;
pfu, plaque forming unit; FDA, food and drug administration; BSE, bovine spongiform encephalopathy;
GMT, geometric mean titer; INF
γ
, interferongamma; TNF
α
, tumor necrosis factoralpha; YF, yellow feve
https://www.tandfonline.com/doi/epdf/10.4161/hv.7.6.14985?needAccess=true
Page updated
Report abuse